7-Peptide Injectable Hair Complex
The world's first CE-approved injectable hair treatment leveraging sustained-release peptide technology to activate follicular regeneration at the molecular level. Not a growth stimulator. A biological reset.
Request Product Information
Activates genes governing follicle development and extends the anagen growth phase.
Suppresses BMP4 and DKK-1 proteins, the primary molecular drivers of hair loss.
Reduces oxidative damage at the follicular level from UV exposure and environmental stress.
Promotes new blood vessel formation to improve nutrient supply to hair follicles.
Peptides enhance the expression of genes involved in hair follicle development and function. The anagen (growth) phase is prolonged, allowing follicles to produce thicker, stronger hair over the full treatment cycle.
Oligopeptide-54 (CG-NOKKIN) specifically targets and suppresses BMP4 and DKK-1, the proteins directly responsible for hair follicle miniaturisation and the onset of androgenetic alopecia.
Targeted antioxidant peptides neutralise reactive oxygen species at the follicular bulb. UV-induced and stress-related oxidative damage, a key contributor to premature hair loss, is measurably reduced.
Peptides promote the formation of new micro-capillaries around the follicular papilla, ensuring consistent delivery of oxygen and nutrients essential for sustained follicular activity and healthy hair production.
Each peptide is selected for a specific, validated biological role. Encapsulated for maximum stability and sustained dermal delivery, outperforming any single-compound therapy.
Stimulates hair follicle cycling and prolongs the anagen growth phase for sustained hair production.
Directly stimulates hair regrowth by activating follicular stem cell populations and papilla cells.
Activates bulge-region stem cells responsible for initiating new follicular growth cycles.
Activates the Wnt/β-catenin signalling cascade, a master regulator of follicular morphogenesis.
Suppresses the key protein drivers of alopecia, halting the miniaturisation cascade at source.
Stimulates collagen production in the dermal papilla, improving the structural support environment for follicles.
Supports follicular architecture and aids scalp wound healing, accelerating post-treatment recovery.
Norwood-Hamilton Classification Stage II through IV-A. Early to moderate androgenetic alopecia in male patients.
Savin Scale Type I-1 through II-2. Central thinning and diffuse loss patterns in female patients.
Early-stage diffuse thinning where follicular activity is reduced but miniaturisation is not yet advanced.
Alopecia areata and telogen effluvium cases without permanent follicular scarring or destruction.
Supports graft survival and surrounding native hair density following hair transplant procedures.
Complete protocol delivered across four treatment appointments for full peptide saturation of the follicular environment.
Fortnightly spacing allows sustained-release peptides to complete their biological action before the next treatment cycle begins.
Initial improvements in hair density and reduced shedding are typically visible after sessions two to three.
Peak results maintained for six to twelve months. Maintenance sessions every three to six months sustain ongoing benefit.
Request a product sample kit, full injection protocol documentation, or clinical outcome data for the ELYARA 7-Peptide Hair Complex. Available to accredited aesthetic and dermatology clinics.